Last reviewed · How we verify
Trachoma
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Doxycyclin · Bulovka Hospital
- Klaron · Merck & Co.
- Azo Gantrisin · Alra
- Abelcet · Astellas Pharma
- Demethylchlortetracycline · Pfizer
- Aureomycin
- Meclan · Johnson And Johnson
- Minocycline Hydrochloride · Rempex
MINOCYCLINE works by inhibiting protein synthesis in bacteria, ultimately leading to their death. - Vibramycin · Generic (originally Pfizer)
- Minocyclin · University of Southern California
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Trachoma patent landscape — cliff calendar, originator estates, attackable patents
- Trachoma treatment landscape brief
- Trachoma treatment updates RSS
Frequently asked questions about Trachoma
What drugs treat Trachoma?
Tracked treatments include Ramycin, Doxycyclin, Klaron, Azo Gantrisin, Abelcet, Demethylchlortetracycline, Aureomycin, Meclan.
What is the treatment for Trachoma?
Standard treatment for Trachoma includes Ramycin, Doxycyclin, Klaron, Azo Gantrisin, Abelcet. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Trachoma patent cliff · Trachoma CI report
- Treatment: Ramycin
- Treatment: Doxycyclin · Bulovka Hospital
- Treatment: Klaron · Merck & Co.
- Treatment: Azo Gantrisin · Alra
- Treatment: Abelcet · Astellas Pharma
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing